Profile data is unavailable for this security.
About the company
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
- Revenue in USD (TTM)271.58bn
- Net income in USD1.87bn
- Incorporated2001
- Employees42.00k
- LocationCencora Inc1 West First AvenueCONSHOHOCKEN 19428United StatesUSA
- Phone+1 (610) 727-7000
- Fax+1 (302) 655-5049
- Websitehttps://www.cencora.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhangzhou Pientzhng Phrmctcl Co Ltd | 1.34bn | 390.19m | 18.87bn | 2.72k | 48.36 | 10.50 | -- | 14.11 | 4.68 | 4.68 | 16.04 | 21.56 | 0.6537 | 2.05 | 13.47 | 3,558,128.00 | 19.55 | 19.02 | 23.73 | 24.40 | 45.61 | 45.90 | 29.90 | 27.27 | 5.02 | -- | 0.0714 | 31.71 | 8.38 | 18.54 | 1.66 | 25.10 | 27.59 | 23.79 |
| Cardinal Health Inc | 216.15bn | 639.00m | 25.78bn | 48.00k | 41.71 | -- | 19.26 | 0.1193 | 2.54 | 2.54 | 856.88 | -14.14 | 4.75 | 11.70 | 18.63 | 4,503,084.00 | 1.41 | -1.13 | 6.56 | -3.08 | 3.34 | 4.00 | 0.2966 | -0.2816 | 0.5017 | 31.29 | 3.70 | -- | 13.04 | 8.43 | 127.97 | -- | 4.61 | 1.40 |
| Cencora Inc | 271.58bn | 1.87bn | 47.34bn | 42.00k | 25.84 | 51.92 | 16.08 | 0.1743 | 9.18 | 9.18 | 1,334.79 | 4.57 | 4.43 | 14.81 | 12.64 | 6,466,177.00 | 3.03 | 0.9542 | 13.95 | 3.95 | 3.37 | 3.14 | 0.6847 | 0.2178 | 0.5162 | 11.93 | 0.8183 | 76.85 | 9.89 | 9.32 | 2.74 | 10.79 | 6.38 | 5.00 |
| McKesson Corp | 301.51bn | 3.00bn | 68.18bn | 45.00k | 23.50 | -- | 17.98 | 0.2261 | 22.07 | 22.07 | 2,223.50 | -15.67 | 4.67 | 13.56 | 13.83 | 6,700,134.00 | 4.89 | 0.6349 | 21.92 | 2.21 | 4.01 | 5.04 | 1.05 | 0.1611 | 0.4959 | 15.38 | 1.40 | 144.13 | 4.83 | 5.84 | 218.41 | -- | -0.7704 | 10.25 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 19.79m | 9.92% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 11.24m | 5.63% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 2023 | 10.48m | 5.25% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 7.90m | 3.96% |
| JPMorgan Investment Management, Inc.as of 31 Dec 2023 | 4.70m | 2.36% |
| Boston Partners Global Investors, Inc.as of 31 Dec 2023 | 4.03m | 2.02% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 3.83m | 1.92% |
| Wellington Management Co. LLPas of 31 Dec 2023 | 3.81m | 1.91% |
| Geode Capital Management LLCas of 31 Dec 2023 | 3.78m | 1.90% |
| Bessemer Investment Management LLCas of 31 Dec 2023 | 3.15m | 1.58% |
